SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: the truth who wrote (648)5/11/1998 7:02:00 AM
From: F. Jay Abella, III  Read Replies (4) of 1185
 
Forthright:

In response to your request -

"Mr Jay Abella, can you give us an overview of the company's plans with respect to the clinical trials (including the timing, size and protocols of these trials) and the market potential of the drugs. A quantitative analysis based on discounted future cash flows would seem appropriate. Thanks for you help."

It sounds like you already know the answers Mr. Forthright.

Care to tell us how that could be? And don't try to suggest that I am incapable of answering your questions. Something tells me you are better informed about NRT than you are leading on.

Are you sore because I have suggested that NRT shares will magically gravitate between a price north of $2.50 and $2.50 due to the incentives of the new warrantholders? If so, then tell us why this phenomenon has already happened to the stock twice in the last three weeks? Are you a warrantholder? Have you exercised any warrants yet? If so, how many? And why so soon?

Given the new set of incentives, my one year target price for NRT is $3.50, settling back to $2.50 after the long money has been made. Then people like Mr. Forthright, who knows damn well that clinical trial plans and discounted cash flows mean far less to the valuations junior biotechs than the number and price of deal sweetening warrants one may or may not hold, can make his money by trying to dupe what he describes as "unsophisticated" investors from their shares by posting messages at SI.

I commend you on your brilliant and original ploy. I wish you luck in your persuasion efforts.

FJA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News